Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Middlefield Canadian Income PCC - Director/PDMR Shareholding

21 Nov 2022 17:09

Middlefield Canadian Income PCC - Director/PDMR Shareholding

Middlefield Canadian Income PCC (the "Company" or “MCT”)

(Including Middlefield Canadian Income – GBP PC (the “Fund”), a cell of the CompanyRegistered No: 93546)Legal Entity Identifier: 2138007ENW3JEJXC8658

21 November 2022

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

As required by Article 19.3 of Regulation (EU) No. 596/2014 on market abuse (the “Market Abuse Regulations”), the Company announces that it was informed on 18 November 2022 of the following transaction by Beg Kaleh Services Limited, a company connected with one of the Company’s directors, Mr Philip Bisson, by virtue of his being a director of the Company.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Beg Keleh Services Limited
2 Reason for the notification
a) Position/status Person closely associated with Philip Bisson, Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Middlefield Canadian Income PCC on behalf of Middlefield Canadian Income – GBP PC
b) LEI 2138007ENW3JEJXC8658
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification code  Redeemable Participating Preference SharesISIN GB00B15PV034
b) Nature of the transaction Purchase
c) Price(s) and volume(s) Price(s) Volume(s)
£1.317,000
d) Aggregated information - Aggregated volume - Price  7,000 @ £1.31£9,170.00
e) Date of the transaction 18 November 2022
f) Place of the transaction London Stock Exchange XLON

Following this transaction, Mr Bisson holds a beneficial interest in 1,241,000 Redeemable Participating Preference Shares, representing 1.17% of the Fund’s issued share capital (excluding treasury shares).

Enquiries:

Hilary JonesJTC Fund Solutions (Jersey) LimitedSecretaryTel.: 01534 700 000`Dean OrricoPresidentMiddlefield International LimitedTel.: 01203 7094016

END OF ANNOUNCEMENT

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.